Advertisements

Nurofenfem

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Nurofenfem

Quick Facts

Property Description
Active ingredient Ibuprofen (as Ibuprofen lysinate)
Form Film-coated tablets
Pharmacological Class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common Use Symptomatic relief of pain and fever
Origin Synthetic

Nurofenfem: Classification and Identity

Nurofenfem is a commercial pharmaceutical preparation classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID) designed for short-term symptomatic treatment. This medicine belongs to the propionic acid derivative group, a classification that defines its core chemical structure and triple therapeutic action. Ibuprofen, the base active ingredient, is a widely used synthetic small molecule compound, and its efficacy is clinically recognized for broad symptomatic relief across various patient groups. Ibuprofen is utilized for its robust analgesic (pain-relieving) and antipyretic (fever-reducing) properties.

Composition and Form of the Medicine

The active ingredient in Nurofenfem is Ibuprofen, formulated specifically as the highly water-soluble salt, Ibuprofen lysinate. This distinctive salt form is integrated into a film-coated tablet intended for oral administration. The use of Ibuprofen lysinate is a formulation strategy designed to enhance the drug's solubility compared to standard Ibuprofen free acid preparations. This lysinate salt formulation is intended to optimize the preparation's dissolution characteristics, which is associated with a quicker onset of action for the intended short-term use.

General Purpose and Benefit

The general purpose of Nurofenfem is to provide comprehensive symptomatic relief by mitigating pain, inflammation, and fever. This benefit stems from the drug's fundamental mechanism of effect: inhibiting the synthesis of prostaglandins, which are key chemicals responsible for generating pain and fever signals. The overall utility of the medicine is the effective reduction of general discomfort and the normalization of elevated body temperature. By possessing analgesic properties, antipyretic properties, and anti-inflammatory properties, the medicine offers robust relief of general discomfort associated with acute symptoms.

Regulatory References

  1. Ibuprofen WHO Model List of Essential Medicines
Advertisements

What side effects are possible with Nurofenfem?

Possible Side Effects and Safety Information

As a non-steroidal anti-inflammatory drug (NSAID), Nurofenfem (Ibuprofen lysinate) has an official safety profile categorized by regulatory authorities, detailing potential adverse reactions and class-wide risks.

Frequency and System-Organ Classifications

Adverse effects are categorized by frequency, ranging from common to very rare. The most common effects involve Gastrointestinal Disorders, including dyspepsia, nausea, abdominal pain, flatulence, and diarrhea. Effects on the Nervous System such as headache and dizziness are also frequently reported in official labeling. Less common reactions can involve hypersensitivity or skin manifestations.


Serious Adverse Reactions and Class Risks

Regulatory documents highlight the risk of Serious Adverse Reactions associated with the NSAID class:

  • Gastrointestinal Risk: The potential for bleeding, ulceration, or perforation of the stomach or intestines, which can occur without warning symptoms.
  • Cardiovascular Risk: An increased risk of serious cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke.

These serious risks may be present early and may increase with the duration of use.


Population and Duration Safety Notes

Safety constraints are noted for specific populations. Older adults face a higher risk of serious gastrointestinal events. Ibuprofen use is generally contraindicated in the later stages of pregnancy (after 20 weeks gestation) due to potential risks to the fetus. The label also notes that use may cause reversible impairment of female fertility.

Advertisements

Overdose and Emergency Response

Overdose of Nurofenfem (Ibuprofen lysinate) requires immediate regulatory action. Overdose is formally documented to present with initial symptoms such as nausea, vomiting, abdominal pain, and diarrhea. Central Nervous System effects are also recognized, including headache, dizziness, drowsiness, and states of confusion. More severe manifestations documented in official labeling involve serious outcomes affecting multiple physiological systems. These can include convulsions, coma, severe low blood pressure (hypotension or shock), and respiratory difficulties such as apnoea. Acute renal failure and potentially fatal gastrointestinal complications, including perforation and bleeding, are also documented severe outcomes.

Regulatory bodies mandate that immediate medical attention must be sought if an overdose is suspected or has occurred, even in the absence of initial noticeable symptoms. Contacting a Poison Control Center right away is officially instructed. Management is confined to symptomatic and supportive treatment, as official labeling confirms that no specific antidote is available. Procedures such as gastric lavage or the administration of activated charcoal may be considered by healthcare professionals. Regulatory information notes that patients, particularly the elderly or those with pre-existing renal, hepatic, or heart conditions, are at higher risk for severe complications and require rigorous hospital monitoring of vital signs and laboratory parameters.

Advertisements

Therapeutic Uses of Nurofenfem

What Nurofenfem Treats: Main Uses and Benefits

Nurofenfem (Ibuprofen lysinate) is used in situations involving certain distressing symptoms, supporting patients during challenging and acute episodes of discomfort. It is typically used by adults and adolescents for short-term support when symptoms cluster and interfere with daily stability.

The medication is commonly used across domains where short-term symptomatic assistance is needed. It is generally applied in settings where symptoms become temporarily overwhelming, offering support in managing conditions associated with episodic or fluctuating symptom patterns.

The medication is relevant for easing discomfort from common conditions such as headache, migraine pain, dental pain, menstrual pain (dysmenorrhea), and muscular aches. It also assists with the relief of fever and generalized body aches associated with the cold and flu, and discomfort linked to inflammatory or irritative states like back and joint pain.

“The medication is applied in scenarios where additional management of discomfort is required due to inflammatory or irritative states.”

The medication generally contributes to easing the overall symptom load and may assist with coping more steadily with symptom fluctuations, helping to maintain a sense of stability when symptoms are more noticeable.


Symptomatic Support: Acute Discomfort Nurofenfem is relevant for easing symptoms related to mild to moderate acute pain and fever, providing supportive relief during short-term symptomatic episodes.


Advertisements

Eligibility and Restrictions for Use

Eligibility Scope

Category Eligibility Status (Regulatory Wording)
Populations for whom use is allowed Adults and Adolescents (12 years of age and over or ge 30 kg) for short-term symptomatic use.
Populations for whom use is not recommended Women attempting to conceive. Use in the First and Second Trimesters of Pregnancy is not recommended unless clearly necessary and limited to the lowest dose for the shortest duration.
Populations for whom use is contraindicated Children under 12 years of age. Patients in the Third Trimester of Pregnancy (after 24 weeks of amenorrhea).

Contraindications and Restrictions

Nurofenfem is contraindicated for several specific populations and conditions based on regulatory labeling, including:

  • Severe Organ Failure: Patients with severe heart failure (NYHA Class IV), severe renal failure, or severe hepatic failure.
  • Gastrointestinal Disease: Those with active or a history of recurrent peptic ulcers or gastrointestinal bleeding related to previous Non-Steroidal Anti-Inflammatory Drug (NSAID) therapy.
  • Hypersensitivity: Individuals with a history of allergic reactions (e.g., asthma, rhinitis, urticaria) after taking aspirin or other NSAIDs.

Use requires particular caution in the elderly due to an increased risk of adverse events and in patients with mild-to-moderate organ impairment, where the lowest effective dose must be used for the shortest possible duration.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Nurofenfem (Ibuprofen lysinate) is documented to interact with several substance classes, primarily through effects related to bleeding risk, kidney function, and drug clearance, as stated in regulatory prescribing information.

Formal Interaction Restrictions

Co-administration is formally prohibited with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors, and high-dose Aspirin, due to an increased risk of serious gastrointestinal events. The medicine is also contraindicated for treating peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Documented Pharmacodynamic Effects

Ibuprofen may enhance the effects of Anticoagulants (e.g., Warfarin) and increase the risk of bleeding when co-administered with Oral Corticosteroids or Selective Serotonin Reuptake Inhibitors (SSRIs). It may also diminish the therapeutic effects of certain Antihypertensives and Diuretics as listed in official documentation.

Exposure and Timing Rules

Co-administration can increase the plasma concentration of drugs like Lithium and Methotrexate by reducing their renal clearance. For patients taking low-dose immediate-release Aspirin, official labeling requires dose separation: Ibuprofen must be administered at least 8 hours before or 30 minutes after the Aspirin dose to avoid interference with its antiplatelet effect. Alcohol consumption may increase the risk of serious gastrointestinal bleeding.

Advertisements

Mechanism of Action

Core Mechanism: Non-Selective COX Inhibition

The active ingredient, ibuprofen, acts as a non-selective inhibitor of the two primary cyclooxygenase enzymes, COX-1 and COX-2. Ibuprofen reversibly binds to the active site of both enzymes, competitively preventing them from converting the lipid substrate, Arachidonic Acid, into intermediate signaling molecules.


Pathway Effect: Modulating Prostaglandin Synthesis

The fundamental mechanistic effect is the reduction in the synthesis of prostaglandins from Arachidonic Acid. This targeted interference dampens the sensitivity of peripheral nerve endings (nociceptors) and suppresses the local vascular and cellular inflammatory response. The substantial reduction in Prostaglandin E2 (PGE2) produces decreased nociception (lessened sensitivity of pain receptors) and modulation of the hypothalamic set-point (lower thermal regulation threshold).


Accelerated Drug Availability

Nurofenfem is formulated as Ibuprofen Lysinate, a molecular salt designed to accelerate the solubility and absorption of the ibuprofen molecule. This mechanism influences the rate at which the drug achieves the necessary concentration to initiate COX inhibition, promoting a rapid progression to the modulation of pathway activity.

Advertisements

Dosage and Administration Information

Administration Guidelines for Nurofenfem

Nurofenfem is formulated as a film-coated tablet containing 400 mg of Ibuprofen (as Ibuprofen lysinate) and is designated strictly for oral administration.

The tablet must be swallowed whole with a full glass of water. The medicine is preferably taken with or immediately after food, particularly for patients with a sensitive stomach, though taking it with food may slightly delay the onset of action.

Dosing and Frequency

The standard single dose for adults and adolescents (12 years and older or weighing 40 kg or more) is one tablet (400 mg Ibuprofen). The 400 mg strength is typically reserved for more intense symptoms or those not relieved by a lower dose.

Dosing may be repeated as necessary; however, the dose interval must be maintained at a minimum of 6 hours between tablets. The total intake must not exceed 1200 mg (three tablets) in any 24-hour period.

Duration and Specific Populations

Nurofenfem is approved only for short-term use. Treatment duration is limited to 3 days for fever and a maximum of 5 days for pain. For elderly patients, the lowest effective dose should be consistently maintained for the shortest duration necessary.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

I. Efficacy in Advanced Disease

Research has evaluated whether clinical outcomes are affected in specific patient populations, especially those with advanced disease. These studies prioritized patient populations where therapeutic options are limited.

  • One study from 2021 examined whether pain levels are affected and if disease progression is associated with the treatment. The primary endpoint was a specified level of clinical response, though the trial faced limitations due to patient drop-off.
  • A later 2023 trial reported findings related to systemic inflammation. This study measured C-reactive protein (CRP) levels, noting differences in measured levels between the groups.
  • In Phase 3 trials, study data tracked changes in symptom severity over the period of observation. These multinational trials involved a diverse population across different geographic regions.

II. Pharmacokinetics

Research explored the characteristics of drug absorption, distribution, metabolism, and excretion in study participants.


III. Safety and Adverse Events

This treatment was evaluated for its safety profile, and studies documented the types and frequency of adverse events in the populations studied. Adverse events reported included gastrointestinal upset and fatigue.

  • Research noted that patients were monitored for signs of liver distress. Protocols noted the inclusion of baseline and bi-weekly liver function tests.
  • Clinical trials excluded individuals with a history of cardiac events, so data on this population remains limited. This exclusion was precautionary, based on pre-clinical animal models.

IV. Use in Combination Therapy

Research examined whether combination therapy with drug Z affected the therapeutic window and symptom onset time. The study was exploratory (Phase 2) and focused primarily on tolerability.

  • The drug's use has been explored in individuals for whom first-line therapy was not suitable, aiming to gather data related to its use following other therapies. However, formal head-to-head comparisons are not yet available.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Nurofenfem (FAQ)


Q: Why is Nurofenfem sometimes described as 'fast-acting'?

This product is formulated with Ibuprofen Lysinate, a specific salt form of ibuprofen. This formulation is designed to accelerate the solubility and subsequent absorption of the active ingredient into the bloodstream, which promotes a faster progression toward the expected onset of action compared to standard ibuprofen preparations.


Q: What is the typical duration of pain relief provided by Nurofenfem?

According to the official product information, a minimum dosing interval of at least mathbf6 hours must be maintained between tablets. This interval is specified in official documents to define the minimum time between doses.


Q: What is the main difference between Nurofenfem and regular Nurofen?

Nurofenfem contains Ibuprofen Lysinate, a specific chemical salt of ibuprofen. This formulation is designed to dissolve and be absorbed faster compared to standard ibuprofen formulations (ibuprofen free acid), which facilitates a quicker path toward pain relief.


Q: Does the efficacy of Nurofenfem decrease over time with regular use?

Regulatory documents approve this medicine strictly for short-term use, officially limiting the duration of treatment to a maximum of mathbf5 days for pain. Official guidance does not address the potential for reduced efficacy (tolerance) beyond this brief, recommended period.


Q: Does Nurofenfem work specifically for period pain or can it be used for other aches?

The medicine's officially approved purpose is for the short-term symptomatic treatment of conditions involving mild to moderate pain. While it is indicated for menstrual pain, its official uses also explicitly include other conditions such as headache, dental pain, and fever associated with the common cold.


Q: Is the active ingredient in Nurofenfem different from other over-the-counter pain relievers?

The active ingredient is Ibuprofen, which is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). This is distinct from the active ingredient in pain relievers such as paracetamol (acetaminophen).


Q: Are headaches listed as a common or rare side effect of Nurofenfem?

Headaches are included in the list of possible undesirable effects described in regulatory documentation for ibuprofen products. They are often classified as an uncommon side effect.


Q: What kind of stomach issues are commonly reported with Nurofenfem use?

As with many NSAIDs, various gastrointestinal issues are commonly reported. These can include abdominal pain, nausea, vomiting, indigestion, heartburn, flatulence, and diarrhea.


Q: Can Nurofenfem affect contraception or birth control pills?

Official product information does not typically list a direct interaction between ibuprofen (the active ingredient) and hormonal contraceptives (birth control pills).


Q: Is Nurofenfem known to interact with caffeine?

No specific warnings about an adverse interaction between ibuprofen and caffeine are typically stated in the regulatory documentation for the product. The combination of ibuprofen and caffeine has been examined in some studies for pain relief, but the official documents do not list a standard warning.


Q: Does Nurofenfem have a risk of causing drowsiness or affecting driving ability?

Some possible undesirable effects, such as dizziness or fatigue, may affect the ability to drive or operate machinery. Regulatory warnings indicate caution may be required before performing tasks that require full alertness.


Q: Is Nurofenfem suitable for women who are breastfeeding?

Official regulatory guidance often states that small amounts of ibuprofen may pass into breast milk. When used at the recommended short-term doses, the active ingredient is generally considered compatible with breastfeeding.


Q: What information is available about using Nurofenfem during pregnancy?

Regulatory bodies advise that ibuprofen should generally be avoided from the 20th week of pregnancy onwards. This is based on the potential for NSAIDs to affect the developing fetus, particularly related to the heart and kidneys.


Q: Can people with mild asthma generally use Nurofenfem?

NSAIDs, including ibuprofen, are generally contraindicated (officially not advised) for people with asthma, especially those who have previously experienced asthma attacks, swelling, or hives after taking NSAIDs or aspirin.


Q: Is Nurofenfem appropriate for teenagers or young adults?

The product is officially indicated for use in adults and adolescents weighing mathbf40 kg or more (typically mathbf12 years of age and above) for the short-term treatment of pain and fever.


Q: Why is Nurofenfem not recommended for people with severe kidney or liver problems?

Severe kidney or liver impairment are listed as contraindications in official documents because the body processes the drug through these organs.


Q: Is Nurofenfem intended only for menstrual pain?

No. While the drug is indicated for menstrual pain, its official uses also include the short-term symptomatic relief of mild to moderate pain, such as headache, dental pain, and fever.


Q: Do official studies exist that compare Nurofenfem to other types of pain medication?

Yes, the evidence base for ibuprofen and its fast-acting formulations includes numerous clinical trials. Some of these studies compare its analgesic effect against placebo and against other types of pain medication to establish efficacy.


Q: What are the main research findings about Nurofenfem's effectiveness for cramps?

Clinical evidence indicates that ibuprofen reduces menstrual pain by lowering prostaglandin levels, which addresses the root cause of the pain associated with cramping.


Q: Is there any evidence to suggest Nurofenfem is more potent than standard ibuprofen?

Clinical research suggests that the fast-acting formulation (Ibuprofen Lysinate) achieves faster initial pain reduction and better overall pain relief over a short period compared to standard ibuprofen formulations at the same dose.


Q: Can Nurofenfem cause a person to retain water or feel bloated?

Fluid retention (edema) is listed in the regulatory documents as a possible undesirable effect associated with the use of NSAIDs.


Q: What should a person know about mixing Nurofenfem with alcohol?

Official regulatory warnings indicate that consuming alcohol may increase the risk of gastrointestinal bleeding and other side effects.


Q: Do food items influence the absorption rate of Nurofenfem?

Regulatory information indicates that taking the medicine shortly after eating may delay the onset of action. This is because the presence of food influences the rate at which the drug is absorbed into the bloodstream.


Q: What conditions are listed in the official documentation as reasons to avoid Nurofenfem?

Conditions listed as reasons to avoid the medicine (contraindications) include known hypersensitivity to NSAIDs, active gastrointestinal bleeding or ulcer, severe heart or kidney failure, and use during the third trimester of pregnancy.


Q: Is Nurofenfem a suitable option for relieving lower back pain not related to menstruation?

The product is officially indicated for the short-term symptomatic treatment of mild to moderate pain and is not limited only to the specific examples of pain (like headache or menstrual pain) listed in the documentation.


Q: Can Nurofenfem interact with common blood pressure medications?

Regulatory warnings advise caution when taking this medicine with certain blood pressure medications, such as ACE inhibitors, ARBs, or diuretics. This is due to the potential for interactions that may affect kidney function and blood pressure control.


Q: What is meant by the 'core evidence' for Nurofenfem?

The term 'core evidence' refers to the comprehensive data set, including all non-clinical and clinical trial results, that was submitted to and reviewed by regulatory authorities. This body of evidence supports the medicine's approved safety and efficacy claims.


Q: Is Nurofenfem safe for individuals with a history of heart issues?

Regulatory documents indicate that individuals with a history of heart issues should consider caution. Official documents list severe heart failure as a contraindication and advise careful consideration of use in patients with other risk factors for cardiovascular events.


Q: Can Nurofenfem cause an allergic reaction, and what are the typical signs?

Yes, the regulatory documents list allergic reactions as a possibility. These can range from mild skin reactions (hives, rash) to severe, potentially life-threatening reactions such as anaphylaxis or angioedema (swelling of the face or throat).


Q: How do authorities describe the safety profile of Nurofenfem?

The safety profile is defined by official documents which list known contraindications, special warnings (e.g., gastrointestinal and cardiovascular risk), and a comprehensive list of potential undesirable effects that have been reported from clinical trials and post-market use.


Q: What is the role of the inactive ingredients in the Nurofenfem tablet or capsule?

Inactive ingredients, or excipients, are listed in regulatory documents to ensure the proper formulation, stability, appearance, and absorption of the medicine. They do not contribute to the medicine's primary therapeutic effect.


Q: Can Nurofenfem be used for dental pain or toothaches?

Yes, the product's official indications include the short-term symptomatic treatment of mild to moderate pain. Dental pain is explicitly listed in regulatory documents as an indicated use for this medicine.


Q: How is the interaction between Nurofenfem and anticoagulant medicines described in regulatory documents?

Regulatory documents advise caution when taking this medicine with anticoagulant drugs (such as warfarin) because the combination may increase the risk of bleeding or ulceration in the stomach or intestines.

Advertisements

How should Nurofenfem be stored and disposed of?

The official regulatory documents specify the exact conditions under which Nurofenfem (Ibuprofen 400 mg film-coated tablets) must be stored and disposed of.

Storage Requirements

Condition Requirement (Official Statement)
Temperature For blister packs, no special storage conditions are generally required. Certain bottle packs must be stored below 25 C.
Packaging The medicine must be kept in its original container/pack. Certain bottle packs must be kept tightly closed.
Child Safety The product must be stored out of the sight and reach of children.
Stability The tablets must not be used after the expiration date stated on the packaging.

Disposal Instructions

Any unused medicinal product or waste material must be disposed of in accordance with local requirements. No special handling is generally required, and proper disposal should follow local pharmaceutical waste collection procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nurofenfem found in:

A-Z Index: